Novo Nordisk is cutting the out-of-pocket prices of its popular weight-loss drug Wegovy and diabetes drug Ozempic for some consumers.

Current customers who pay for the drugs out of pocket — without the help of health insurance — will now be charged $349 per month, down from $499, the Danish drugmaker said Monday.

Novo Nordisk also announced that it will charge $199 per month for new patients who pay for the drugs out of pocket, with the offer covering two months of the treatments. After that, the cost of the drugs will rise to $349 per month. The introductory $199 offer will be available through March 31, 2026, it said.

The new pricing for people who pay out of pocket for the two popular drugs comes amid a push from the Trump administration to lower their prices . In a deal announ

See Full Page